Loading…
Oaktree Acquisition Corp. III Life Sciences is projected to rise to $14.80 by 2027, a +39% move from its current price of $10.68. OACC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $10.66 | $10.69 | $10.72 | +0.09% |
| May 30 | $10.66 | $10.70 | $10.74 | +0.18% |
| May 31 | $10.66 | $10.71 | $10.76 | +0.27% |
| Jun 1 | $10.66 | $10.72 | $10.78 | +0.36% |
| Jun 2 | $10.67 | $10.73 | $10.79 | +0.45% |
| Jun 3 | $10.67 | $10.74 | $10.81 | +0.55% |
| Jun 4 | $10.67 | $10.75 | $10.82 | +0.64% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.67 | $10.75 | $10.82 | +0.64% |
| Week 2 | $10.71 | $10.82 | $10.92 | +1.28% |
| Week 3 | $10.76 | $10.89 | $11.02 | +1.92% |
| Week 4 | $10.80 | $10.95 | $11.11 | +2.57% |
| Week 5 | $10.85 | $11.02 | $11.20 | +3.22% |
| Week 6 | $10.91 | $11.09 | $11.28 | +3.88% |
| Week 7 | $10.96 | $11.16 | $11.37 | +4.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. It is categorized in Financial Services.
The company was founded in 1995 and is headquartered in Los Angeles, California.
OACC is currently priced at $10.70 per share. Its market cap stands at $263.04M, and its market rank is 3636.
The 30-day range is $10.52 to $10.88, indicating a tight trading band around the current price.
The forecast indicates a bullish longer-term path, with the average price rising across years. For example, the 2026 average is $10.70, the 2030 average is $18.66, and the 2050 average is $84.12.
These figures are estimates and not guarantees; they reflect the projected path under the provided forecast data.
A major floor 1.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.7% away) — a key level to hold.
Price is pressing into resistance (0.5% away) — a breakout level to watch.
A major ceiling 1.1% above — clearing it would confirm fresh momentum.
Key OACC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OACC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.69 | Sell | $10.69 | Sell |
| MA 10 | $10.68 | Buy | $10.68 | Buy |
| MA 20 | $10.65 | Buy | $10.67 | Buy |
| MA 50 | $10.65 | Buy | $10.65 | Buy |
| MA 100 | $10.65 | Buy | $10.64 | Buy |
| MA 200 | $10.59 | Buy | $10.58 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.25 | Neutral |
| Stoch RSI (14) | 48.29 | Neutral |
| CCI (20) | 49.07 | Neutral |
| Williams %R (14) | -41.67 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 0.66 | Buy |
| Bollinger %B (20,2) | 0.67 | Neutral |
| Stochastic %K (14) | 58.33 | Neutral |
| TRIX (15) | 0.01 | Buy |
| Awesome (5,34) | 0.04 | Buy |
| Ultimate (7,14,28) | 68.41 | Neutral |
| Momentum (10) | 0.04 | Buy |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 10.69 | Sell |
| ADX (14) | 13.34 | Neutral |
| ATR (14) | 0.02 | Info |
Sentiment is BULLISH. The RSI14 is 60, with the SMA50 at $10.65 and the SMA200 at $10.59.
Support is at $10.60 and resistance at $10.73, framing a narrow near-term trading range. The 30-day range spans $10.52 to $10.88, highlighting limited price movement in the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.56 | $10.68 | $14.66 | 0% | Neutral | |
| $12.08 | $14.80 | $18.98 | +39% | Bullish | |
| $13.26 | $16.55 | $21.79 | +55% | Bullish | |
| $14.06 | $17.82 | $23.96 | +67% | Bullish | |
| $14.41 | $18.50 | $25.32 | +73% | Bullish | |
| $15.50 | $20.15 | $28.02 | +89% | Bullish | |
| $17.87 | $23.49 | $33.12 | +120% | Bullish | |
| $20.38 | $27.08 | $38.67 | +154% | Bullish | |
| $22.79 | $30.59 | $44.21 | +186% | Bullish | |
| $23.81 | $32.26 | $47.16 | +202% | Bullish | |
| $36.78 | $52.00 | $79.66 | +387% | Bullish | |
| $55.37 | $84.05 | $138.08 | +687% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $10.56 | $10.68 | $12.51 | +0.00% |
| June 2026 | $9.50 | $11.08 | $13.18 | +3.77% |
| July 2026 | $9.88 | $11.60 | $13.93 | +4.67% |
| August 2026 | $9.88 | $11.64 | $14.09 | +0.37% |
| September 2026 | $9.80 | $11.59 | $14.11 | -0.42% |
| October 2026 | $10.02 | $11.90 | $14.56 | +2.61% |
| November 2026 | $10.11 | $12.05 | $14.81 | +1.26% |
| December 2026 | $9.93 | $11.87 | $14.66 | -1.49% |
Click any year to see its month-by-month OACC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, OACC is projected to trade between $10.56 and $14.66, averaging $10.68 — a potential gain of 0% from today's $10.68. A consolidation phase looks the most probable path here.
Oaktree Acquisition Corp. III Life Sciences's 2027 outlook centres on $14.80, within a $12.08 to $18.98 range. That is up +39% on the projected 2026 average. That marks a +39% change versus current levels. Momentum favours further upside here.
By 2028, OACC could reach as high as $21.79, with a base case around $16.55 and support toward $13.26 — roughly +55% from $10.68. Buyers look set to stay in control over this stretch.
Expect OACC to range from $14.06 to $23.96 through 2029. The $17.82 average target implies a +67% move from current prices. That is up +8% on the projected 2028 average. Momentum favours further upside here.
The OACC price prediction for 2030 points to an average of $18.50 (low $14.41, high $25.32) — a potential gain of +73% on today's $10.68. Buyers look set to stay in control over this stretch.
In 2031, OACC is projected to trade between $15.50 and $28.02, averaging $20.15 — a potential gain of +89% from today's $10.68. That is up +9% on the projected 2030 average. Momentum favours further upside here.
Oaktree Acquisition Corp. III Life Sciences's 2032 outlook centres on $23.49, within a $17.87 to $33.12 range. That is up +17% on the projected 2031 average. That marks a +120% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, OACC could reach as high as $38.67, with a base case around $27.08 and support toward $20.38 — roughly +154% from $10.68. Momentum favours further upside here.
Expect OACC to range from $22.79 to $44.21 through 2034. The $30.59 average target implies a +186% move from current prices. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The OACC price prediction for 2035 points to an average of $32.26 (low $23.81, high $47.16) — a potential gain of +202% on today's $10.68. Momentum favours further upside here.
In 2040, OACC is projected to trade between $36.78 and $79.66, averaging $52.00 — a potential gain of +387% from today's $10.68. That is up +61% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Oaktree Acquisition Corp. III Life Sciences's 2050 outlook centres on $84.05, within a $55.37 to $138.08 range. That is up +62% on the projected 2040 average. That marks a +687% change versus current levels. Momentum favours further upside here.
Investing $1,000 in OACC today (≈ 93.632959 OACC) could be worth
$7,870
+$6,870 (+687%) by 2050 · US Dollar
Based on the average projected OACC price of $84.05 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OACCwould be worth at today's price.
$1,000 invested in OACC on May 27, 2025 (≈ 95.914064 OACC) would be worth
$1,024.36
+$24.36 (+2.4%) today · 1.02× · US Dollar
Based on a OACC entry price of $10.43 vs. today's $10.68.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.7 | $998.13 | -0.2% |
| 1 month ago | $10.68 | $1,000 | -0.0% |
| 3 months ago | $10.7 | $998.13 | -0.2% |
| 6 months ago | $10.56 | $1,011.36 | +1.1% |
| 1 year ago | $10.43 | $1,024.36 | +2.4% |
| All time (1.4y) ago | $10 | $1,068 | +6.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OACC forecast.
Our base-case forecast reaches $21.00 around 2032.
Implied market cap at $21.00: $415.44M
The multi-year forecast shows bullish sentiment across the forecast horizon, with rising averages and sizable upside potential.
In 2026, the average price is $10.70 with a range from $10.56 to $14.69 and ROI of 0, reflecting a neutral stance before a stronger move in later years. By 2027 the average is $14.94 with ROI 39.7 and sentiment bullish, continuing to rise through 2028 ($16.58 avg, ROI 55) and 2029 ($17.79 avg, ROI 66.3).
By 2030 the average is $18.66 with ROI 74.4, and the forecast extends to 2031 ($20.21 avg, ROI 88.9) and 2032 ($23.56 avg, ROI 120.2). The path continues higher with 2033 at $27.30 avg (ROI 155.1), 2034 at $30.61 avg (ROI 186.1), and 2035 at $32.37 avg (ROI 202.5).
Longer-term milestones include 2040 with an average of $52.11 (ROI 387) and 2050 with an average of $84.12 (ROI 686.1), both reflecting bullish sentiment. These are projections and depend on market conditions and other factors; actual results may differ.
Tap a question to reveal the answer.
Avg $18.66; min $14.52; max $25.56; ROI 74.4% (forecasted values).
Forecast shows bullish sentiment from 2027 onward with rising averages and ROI up to 686.1% by 2050; 2026 shows neutral with avg $10.70. These are estimates, not guarantees.
Forecasted 2040 average is $52.11 with min $36.81, max $79.94 and ROI 387%.
2030–2050 forecasts show continued upside, with 2050 average $84.12 and ROI 686.1; the 2040 milestone is $52.11 average, with a wide range around it.
Current price is $10.70 and market cap is $263.04M (rank 3636).
Oaktree Acquisition Corp. III Life Sciences Community Discussion
0Share your Oaktree Acquisition Corp. III Life Sciences price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.